Sort
21,453 grants matching “tuberculosis”
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
$1,290,372Case Western Reserve University · R01 · FY2005 · AI
Development Of New Chemotherapeutics For Tuberculosis
$1,289,021Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Development Of New Chemotherapeutics For Tuberculosis
$1,288,544Clifton Barry · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM
$1,288,057Nancy Baruch · Maryland State Department Of Health · U52 · FY2011 · PS
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,287,739Mark Fredric Cotton · Stellenbosch University · UM1 · FY2017 · AI
Exploring the metabolism of non-replicating and drug-resistant TB
$1,286,564Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Re-evaluating the Duration in Children of TB Treatment (REDUCE TB): A Phase 2 Duration Randomized Trial
$1,286,549Anthony Joseph Garcia-Prats · University Of Wisconsin-Madison · U01 · FY2025 · AI
Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb
$1,284,246David Alland · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Chicago Clinical Trials Unit
$1,284,164Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2021 · AI
Vaccine and Treatment Evaluation Units
$1,282,926Nadine Georges Rouphael · Emory University · UM1 · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM
$1,282,245Nancy Baruch · Maryland State Department Of Health · U52 · FY2010 · PS
Natural History of HIV Infection in Injection Drug Users
$1,281,995Johns Hopkins University · R37 · FY2003 · DA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,280,720Johns Hopkins University · U01 · FY2002 · AI
Chemically Modified Peptide Nucleic Acids
$1,280,656Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
GENERAL CLINICAL RESEARCH CENTER
$1,280,194Yeshiva University · M01 · FY2000 · RR
Integrated Care Clinics for IDUs in India: a cluster randomized trial
$1,279,936Gregory M Lucas · Johns Hopkins University · R01 · FY2012 · DA
Johns Hopkins University Kampala-Nanning Clinical Trial Unit
$1,279,706Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2015 · AI
Genes/Pathways for Autophagy-dependent inhibition of Bacterial Infections
$1,278,288Ramnik J Xavier · Washington University · U19 · FY2014 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
$1,278,151Adithya Cattamanchi · University Of California-Irvine · R01 · FY2024 · AI
Human MAIT celis in airway mucosal immune responses to intracellular infections
$1,277,830David M. Lewinsohn · Oregon Health & Science University · U01 · FY2015 · AI
Human MAIT celis in airway mucosal immune responses to intracellular infections
$1,277,830David M. Lewinsohn · Oregon Health & Science University · U01 · FY2014 · AI
Viable but Nonculturable Mtb
$1,277,246Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI
International Tuberculosis Clinical Research
$1,276,926Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,276,503Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2023 · AI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$1,276,123Herbert W Virgin · Washington University · U19 · FY2017 · AI